Search hospitals

>

Montana

>

Kalispell

Kalispell Regional Medical Center

Claim this profile

Kalispell, Montana 59901

Global Leader in Breast Cancer

Global Leader in Lung Cancer

Conducts research for Cancer

Conducts research for Breast cancer

Conducts research for Pancreatic Cancer

510 reported clinical trials

3 medical researchers

Photo of Kalispell Regional Medical Center in KalispellPhoto of Kalispell Regional Medical Center in Kalispell

Summary

Kalispell Regional Medical Center is a medical facility located in Kalispell, Montana. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Pancreatic Cancer and other specialties. Kalispell Regional Medical Center is involved with conducting 510 clinical trials across 537 conditions. There are 3 research doctors associated with this hospital, such as John M. Schallenkamp, Benjamin T. Marchello, and Alison Schneider.

Area of expertise

1

Breast Cancer

Global Leader

Kalispell Regional Medical Center has run 90 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
HER2 negative
ER positive
2

Lung Cancer

Global Leader

Kalispell Regional Medical Center has run 74 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage II

Top PIs

Clinical Trials running at Kalispell Regional Medical Center

Bladder Cancer

Lung Cancer

Prostate Cancer

Cancer

Breast Cancer

Breast cancer

Ovarian Cancer

Esophageal cancer

Melanoma

Bladder Carcinoma

Image of trial facility.

Eribulin + Chemotherapy

for Bladder Cancer

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.

Recruiting

2 awards

Phase 3

Image of trial facility.

Gemcitabine + Docetaxel vs BCG

for Bladder Cancer

This trial is testing whether a combination of two drugs, Gemcitabine and Docetaxel, given directly into the bladder, is effective for patients with high-grade non-muscle invasive bladder cancer who have not been treated with the standard therapy before. The goal is to see if this new treatment can prevent cancer from coming back or spreading. The study will also look at the quality of life, safety, and side effects of the new treatment. Gemcitabine and Docetaxel have shown promise as an alternative treatment, especially in cases where the standard therapy fails or is not tolerated.

Recruiting

2 awards

Phase 3

14 criteria

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Kalispell Regional Medical Center?

Where is Kalispell Regional Medical Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does Kalispell Regional Medical Center accept?

What awards or recognition has Kalispell Regional Medical Center received?